Related Experiment Video
Updated: May 27, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Natural Plant Bioactives as Regulators of Histone Modifications: Bridging Epigenetics and Anticancer Therapy
Mengxiao Wang1, Junyi Liang1, Xinping Zhu1
1Heilongjiang University of Chinese Medicine, Harbin, China.
Abstract:
Cancer remains a leading cause of global mortality, with tumor heterogeneity, recurrence, metastasis, and drug resistance posing significant challenges to conventional therapies, which are often limited by toxicity and efficacy. Epigenetic regulation, particularly histone modifications such as methylation, acetylation, phosphorylation, and lactylation, plays a pivotal role in orchestrating gene expression and tumor progression, representing promising yet complex therapeutic targets. Bioactive compounds derived from natural plants, characterized by multi-target activity and low toxicity, have emerged as potent modulators of histone modifications, capable of influencing tumor growth, metastasis, and the tumor microenvironment. Here, we provide a comprehensive review of recent advances elucidating how natural products influence cancer progression and reshape the tumor immune microenvironment by regulating histone modifications. We integrate current knowledge of key histone marks, modifying enzymes, and signaling pathways, proposing a unified framework linking natural compounds, epigenetic regulation, and tumorigenesis. By uncovering these molecular mechanisms, we highlight that plant bioactive compounds can reshape the tumor immune microenvironment through histone modifications to inspire the development of novel, safer, and more effective anticancer agents.
Insights
Natural plant compounds can modify cancer cell epigenetics, specifically histone modifications, to combat tumor growth and metastasis. This research explores how these compounds reshape the tumor microenvironment for novel cancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Natural Products Chemistry
Background:
- Cancer presents significant challenges due to tumor heterogeneity, recurrence, metastasis, and drug resistance.
- Conventional cancer therapies face limitations in toxicity and efficacy.
- Epigenetic regulation, including histone modifications, is crucial in cancer progression and offers therapeutic potential.
Purpose of the Study:
- To review recent advances on how natural products modulate histone modifications in cancer.
- To elucidate the mechanisms by which plant-derived compounds influence cancer progression and the tumor immune microenvironment.
- To propose a framework linking natural compounds, epigenetic regulation, and tumorigenesis.
Main Methods:
- Comprehensive literature review of recent advances.
- Integration of knowledge on histone marks, modifying enzymes, and signaling pathways.
- Analysis of molecular mechanisms of natural product action on cancer epigenetics.
Main Results:
- Natural plant compounds act as potent modulators of histone modifications (e.g., methylation, acetylation, lactylation).
- These compounds influence tumor growth, metastasis, and the tumor microenvironment.
- A unified framework is proposed linking natural compounds, epigenetic regulation, and cancer development.
Conclusions:
- Plant bioactive compounds can reshape the tumor immune microenvironment via histone modification.
- Understanding these mechanisms can lead to the development of novel, safer, and more effective anticancer agents.
- Natural products represent a promising avenue for cancer therapy by targeting epigenetic mechanisms.
More Related Videos
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...

